PUBLISHER: DelveInsight | PRODUCT CODE: 1776218
PUBLISHER: DelveInsight | PRODUCT CODE: 1776218
Meniscus Repair Systems Market by Product Type (All-Inside Repair System, Inside-Out Repair System, Outside-In Repair System, and Meniscal Root Repair System), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2032 owing to the rising cases of musculoskeletal conditions and associated risk factors, increasing preference for minimally invasive meniscus repairs, and increasing product development and launches activities by key players.
The meniscus repair systems market was valued at USD 506.42 million in 2024, growing at a CAGR of 5.69% during the forecast period from 2025 to 2032 to reach USD 786.43 million by 2032. The demand for meniscus repair systems is on the rise, driven by several key factors. These include the growing incidence of musculoskeletal conditions caused by sports and bone-related injuries, as well as risk factors such as a growing aging population and others. Additionally, the increasing awareness and preference for minimally invasive meniscus repair procedures, which involve small incisions and the use of specialized instruments to access and repair the torn meniscus. Moreover, increasing product development and new product launches by key market players are contributing to this growth. Together, these trends are creating a favorable environment for sustained expansion, positioning the meniscus repair systems market for robust and consistent growth throughout the forecast period from 2025 to 2032.
Meniscus Repair Systems Market Dynamics:
According to the World Health Organization (2023), over 344 million individuals were affected by osteoarthritis globally, while approximately 1.71 billion people suffered from musculoskeletal disorders in 2022.
In the UK, the National Institute for Health and Care Research (2024), estimated that around 700,000 people were living with rheumatoid arthritis (RA) in 2024. Similarly, data from the Australian Bureau of Statistics showed that more than 3.7 million Australians, accounting for 14.5% of the population, had arthritis in 2022. In Germany, the National Institute of Health (2023) reported that over 1 million patients are diagnosed annually with knee osteoarthritis. Such cases of musculoskeletal conditions are increasing worldwide which is creating the demand for meniscus repair devices for the treatment of these conditions.
The growing prevalence of arthritis and knee osteoarthritis is significantly driving demand for meniscal repair devices. As joint-preserving, minimally invasive treatments become increasingly preferred over traditional surgical approaches, early intervention through meniscal repair is gaining traction. These procedures not only help preserve knee function but also slow disease progression, contributing to improved long-term outcomes for patients thereby boosting the overall market of meniscus repair system.
Moreover, according to data from the National Institute of Health (2023), approximately 400,000 ACL reconstruction procedures were performed annually in the United States. Meniscus repair devices are frequently utilized during these procedures, as meniscal injuries often accompany ACL tears. These devices, designed to place sutures entirely within the joint, are especially effective in treating radial tears along the meniscus fibers. Their use in conjunction with ACL reconstruction is further boosting demand, thereby contributing significantly to the growth of the meniscus repair devices market.
In addition, sports injuries remain a major contributor to meniscal damage, particularly among young and active individuals. According to the Australian Institute of Health and Welfare (2024), approximately 56,000 sports-related injuries resulted in hospital stays in 2022 alone. Similarly, data from Germany's National Institute of Health (2023) reported over 2 million sports injuries annually. This rising incidence of sports-related trauma, which often leads to meniscal tears, is creating a growing need for effective repair solutions.
The increasing frequency of such injuries is accelerating the adoption of meniscus repair systems, as athletes seek faster recovery and quicker return to physical activity.
Moreover, leading players in the market are actively investing in the development of innovative devices to enhance the effectiveness of meniscus tear treatments, which is further propelling market growth. For instance, in October 2024, Regenity Biosciences announced that it had received FDA 510(k) clearance to market RejuvaKneeTM, a minimally invasive, collagen-based meniscal implant. This advanced device is designed to reinforce and repair soft tissue injuries of the meniscus, offering a novel solution for patients seeking joint-preserving treatment options. Such advancements are expanding the therapeutic landscape and accelerating the adoption of meniscus repair systems worldwide.
Collectively, the rising burden of arthritis, the surge in sports injuries, and the growing preference for minimally invasive, joint-preserving techniques are expected to fuel strong and sustained growth in the global meniscus repair systems market throughout the forecast period from 2025 to 2032.
However, the risk of postoperative complications associated with meniscus repair devices and the high cost of procedure and devices, among others are some of the key constraints that may limit the growth of the meniscus repair systems market.
Meniscus Repair Systems Market Segment Analysis:
Meniscus Repair Systems Market by Product Type (All-Inside Repair System, Inside-Out Repair System, Outside-In Repair System, and Meniscal Root Repair System), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the product type segment of the meniscus repair systems market, the all-inside repair system category is estimated to account for the largest market share in 2024. The growth of this category is primarily fueled by the rising incidence of sports-related and traumatic knee injuries, combined with the growing clinical adoption and expanded applications of all-inside meniscus repair devices.
All-inside repair devices offer a minimally invasive solution for meniscal repair, requiring fewer incisions and causing less disruption to surrounding soft tissues. This translates to several key patient benefits, including reduced postoperative pain, faster recovery times, and minimal scarring. Since the entire procedure is performed within the joint capsule, the risk of neurovascular injury such as damage to the saphenous or peroneal nerves and adjacent blood vessels, is significantly reduced.
Moreover, these systems eliminate the need for posterior incisions and reduce reliance on accessory instrumentation, thereby lowering the risk of complications, including infections and prolonged recovery periods. Their design allows surgeons to effectively access and treat complex tear locations such as the posterior horn, and mid-body, and select anterior horn tears, making them particularly valuable for anatomically challenging cases.
Some of the key products in this category underscore the value of innovation in driving market growth. For example, the TRUESPANTM meniscal repair system by Johnson & Johnson MedTech is engineered to simplify and streamline the repair process. Similarly, the FAST-FIX 360 all-inside system by Smith+Nephew offers quick, reproducible implant deployment, smaller insertion points, and enhanced control enabling surgeons to optimize knee function and joint stability while preserving as much of the native meniscus as possible.
Thus, the factors mentioned above are likely to boost the market segment and thereby increase the overall market of meniscus repair systems across the globe.
North America is expected to dominate the overall meniscus repair systems market:
North America is expected to hold the largest share of the meniscus repair systems market in 2024, among all other regions. This dominance is primarily driven by the increasing prevalence of musculoskeletal conditions especially within the aging population along with growing awareness and preference for minimally invasive meniscus repair procedures. Additionally, continuous advancements in product development and regulatory approvals are further contributing to the region's leading position.
According to the Centers for Disease Control and Prevention (CDC), in 2024, approximately 53 million adults in the U.S. were living with arthritis, a number expected to rise significantly as the population ages. Similarly, the Arthritis Society Canada reported that about 6 million people (1 in 5 adults) were affected by arthritis in Canada in 2024. Additionally, data from the National Institutes of Health (NIH, 2023) revealed that over 4 million Canadians were diagnosed with knee osteoarthritis in 2023.
This rising prevalence of arthritis and knee osteoarthritis is significantly driving the growth of the meniscus repair device market in North America. These chronic joint conditions often lead to meniscal damage, fueling the demand for surgical interventions and advanced repair technologies.
Compounding this demand is the high incidence of acute knee injuries. The National Safety Council (2023), reported that 3.7 million individuals were treated in emergency departments for sports and recreational injuries in the United States. This growing burden of both chronic and acute knee conditions is increasing the adoption of meniscus repair devices, particularly minimally invasive systems that enable quicker recovery and joint preservation.
Supporting this trend, a recent study published by the American Academy of Orthopaedic Surgeons (2023), highlighted that over 700,000 meniscal procedures were performed annually in the United States, underscoring the high procedural volume and continued need for effective meniscus repair solutions.
The market growth is further strengthened by continuous product innovation and favorable regulatory advancements. For example, in April 2025, Native Orthopedics, Inc. received FDA clearance for its groundbreaking Native Root System powered by DragonflyTM an advanced solution specifically developed for meniscal root repair. This system features two single-use, sterile-packed dragonfly devices, meticulously designed to reapproximate a torn meniscal root to its native anatomical footprint, thereby supporting more precise, efficient, and durable surgical outcomes.
Collectively, the rising burden of joint diseases, increasing sports-related injuries, growing procedural volumes, and the launch of innovative repair solutions are expected to drive robust growth in the North American meniscus repair systems market throughout the forecast period from 2025 to 2032.
Meniscus Repair Systems Market Key Players:
Some of the key market players operating in the meniscus repair systems market include Stryker, Johnson & Johnson Services, Inc., Smith+Nephew, Arthrex, Inc., Biotek, Zimmer Biomet, CONMED Corporation, Abanzamed, Native Orthopaedics, Regenity, NovoPedics, Inc., Auxein, CHANGZHOU MEDITECH TECHNOLOGY CO., LTD., Atro Medical B.V., Arcuro Medical, OrthoPreserve, Healthium Medtech Limited, and others.
Recent Developmental Activities in the Meniscus Repair Systems Market:
Key takeaways from the meniscus repair systems market report study
Target audience who can benefit from this meniscus repair systems market report study
Frequently Asked Questions for the Meniscus Repair Systems Market: